Notably, most of these TGFβ regulated matrix proteins are markers of poor prognosis in different types of cancers, and some of them are also upregulated in the blood of tumor patients (Fig. 1b) according to the database of the Human Protein Atlas [19, 20]. This evidence concerns the gene TGFB1 and cancer.